Krakow, Poland – 30 May 2018 – Selvita is participating and presenting at the 4th Annual Immuno-Oncology BD&L and Investment Forum, taking place on June 1st, 2018, in Chicago, USA during the first day of American Society of Clinical Oncology (ASCO).
The presentation will be held by Dr. Krzysztof Brzozka, Chief Scientific Officer at Selvita, on June 1, at 3:00 pm in the Sinclair Ballroom during Track D in Waldorf Astoria Chicago.
Dr. Brzozka will provide a corporate and scientific overview of the Company’s recent activities, focusing on the most recent developments of its R&D oncology pipeline, strategic discovery collaborations and plans for the further development.
IOBDLI Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment.
To contact Selvita’s delegates at this conference, please contact us at: email@example.com, or +48 539 939 584.